Sawgrass Asset Management LLC Eli Lilly & CO Transaction History

Sawgrass Asset Management LLC

$955 Million
Q3 2024

A detailed history of Sawgrass Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sawgrass Asset Management LLC holds 20,255 shares of LLY stock, worth $15.2 Million. This represents 1.88% of its overall portfolio holdings.

Number of Shares

20,255

Previous 20,959 3.36%

Holding current value

$15.2 Million

Previous $19 Million 5.43%

% of portfolio

1.88%

Previous 2.06%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $543,586 - $675,854	-704 Reduced 3.36%	20,255 $17.9 Million
Q2 2024 Jul 18, 2024	SELL	$724.87 - $909.04 $3.25 Million - $4.08 Million	-4,486 Reduced 17.63%	20,959 $19 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $1.11 Million - $1.49 Million	-1,875 Reduced 6.86%	25,445 $19.8 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $415,950 - $490,350	-792 Reduced 2.82%	27,320 $15.9 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $7.73 Million - $10.7 Million	17,774 Added 171.93%	28,112 $15.1 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $2.5 Million - $3.34 Million	7,123 Added 221.56%	10,338 $4.85 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $250,057 - $293,680	-805 Reduced 20.02%	3,215 $1.1 Million
Q1 2022 May 18, 2022	BUY	$234.69 - $291.66 $943,453 - $1.17 Million	4,020 New	4,020 $1.15 Million
Q4 2021 Feb 03, 2022	SELL	$224.85 - $279.04 $903,897 - $1.12 Million	-4,020 Closed	0 $0
Q2 2019 Jul 23, 2019	SELL	$110.79 - $129.32 $53,179 - $62,073	-480 Reduced 10.67%	4,020 $445,000
Q2 2017 Aug 11, 2017	BUY	N/A	4,500	4,500 $370,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.

Account

Sawgrass Asset Management LLC Eli Lilly & CO Transaction History